Intra-tumor heterogeneity from a cancer stem cell perspective - PubMed
- ️Sun Jan 01 2017
Review
Intra-tumor heterogeneity from a cancer stem cell perspective
Pramudita R Prasetyanti et al. Mol Cancer. 2017.
Abstract
Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra-tumor heterogeneity). The latter includes phenotypic diversity such as cell surface markers, (epi)genetic abnormality, growth rate, apoptosis and other hallmarks of cancer that eventually drive disease progression and treatment failure. Cancer stem cells (CSCs) have been put forward to be one of the determining factors that contribute to intra-tumor heterogeneity. However, recent findings have shown that the stem-like state in a given tumor cell is a plastic quality. A corollary to this view is that stemness traits can be acquired via (epi)genetic modification and/or interaction with the tumor microenvironment (TME). Here we discuss factors contributing to this CSC heterogeneity and the potential implications for cancer therapy.
Keywords: Cancer stem cell; Stemness; Tumor heterogeneity; Tumor microenvironment.
Figures

The original CSC model (unidirectional hierarchy) assumes that only CSCs are able to generate the bulk of tumor via symmetric division (to self-renew) or asymmetric division (to generate differentiated cells). In this case, the hierarchy is strictly unidirectional and precludes the concept of cell fate reversibility from the progenitor cells. In contrast, accumulating evidence demonstrate that the hierarchy is more fluid than originally thought. In the CSCs plasticity model, (cancer) cell posses the dynamic ability of bidirectional conversion from a non-CSC state to a CSC state and vice versa. In this model, the stemness and CSCs plasticity are determined by diverse intrinsic and extrinsic cues that work simultaneously or independently overtime. Consequently, non-CSCs can serve as reservoir to create CSC populations throughout tumorigenesis. In the figure this is indicated with a lightning bolt and can be the result of a microenvironmental cue or a (epi-)genetic change

Next to intrinsic factors, the tumor microenvironment plays a crucial role in influencing cell state. The tumor microenvironment, in addition to hosting the tumor cells, possess a dynamic topography within the tumor involving diverse supportive ECM scaffolds, growth factors, a vascular bed and immune cell interactions [6]. The right combination of microenvironment components, for example inflammation, hypoxia, vascularized niche or rigid matrix, potentially contribute to stemness and enhanced tumorigenicity [52, 62, 68, 87, 91]. Multiple (distinct) niches may co-exist within a tumor, leading to cellular diversity
Similar articles
-
Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M, Farhood B, Mortezaee K. Najafi M, et al. J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417375 Review.
-
Cancer stem cell: fundamental experimental pathological concepts and updates.
Islam F, Qiao B, Smith RA, Gopalan V, Lam AK. Islam F, et al. Exp Mol Pathol. 2015 Apr;98(2):184-91. doi: 10.1016/j.yexmp.2015.02.002. Epub 2015 Feb 7. Exp Mol Pathol. 2015. PMID: 25659759 Review.
-
Neelakantan D, Drasin DJ, Ford HL. Neelakantan D, et al. Cell Adh Migr. 2015;9(4):265-76. doi: 10.4161/19336918.2014.972761. Epub 2014 Oct 16. Cell Adh Migr. 2015. PMID: 25482627 Free PMC article. Review.
-
Cancer cell plasticity: Impact on tumor progression and therapy response.
da Silva-Diz V, Lorenzo-Sanz L, Bernat-Peguera A, Lopez-Cerda M, Muñoz P. da Silva-Diz V, et al. Semin Cancer Biol. 2018 Dec;53:48-58. doi: 10.1016/j.semcancer.2018.08.009. Epub 2018 Aug 18. Semin Cancer Biol. 2018. PMID: 30130663 Review.
-
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K, Ham SW, Kim H. Eun K, et al. BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222. BMB Rep. 2017. PMID: 27998397 Free PMC article. Review.
Cited by
-
Geng H, Guo M, Xu W, Zang X, Wu T, Teng F, Wang Y, Liu X, Wang X, Sun Q, Liang J. Geng H, et al. Front Endocrinol (Lausanne). 2021 Feb 26;11:613879. doi: 10.3389/fendo.2020.613879. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33716952 Free PMC article. Retracted.
-
Zang J, Zheng MH, Cao XL, Zhang YZ, Zhang YF, Gao XY, Cao Y, Shi M, Han H, Liang L. Zang J, et al. Cell Commun Signal. 2020 Aug 26;18(1):135. doi: 10.1186/s12964-020-00598-7. Cell Commun Signal. 2020. PMID: 32843056 Free PMC article.
-
Fan Y, Gao Z, Xu J, Wang H, Guo Q, Xue H, Zhao R, Guo X, Li G. Fan Y, et al. Front Immunol. 2022 Sep 8;13:986615. doi: 10.3389/fimmu.2022.986615. eCollection 2022. Front Immunol. 2022. PMID: 36159816 Free PMC article.
-
Wang W, Zhang Z, Li W, Wei D, Xu J, Qian Y, Cao S, Lei D. Wang W, et al. Aging (Albany NY). 2023 Nov 10;15(21):12588-12617. doi: 10.18632/aging.205201. Epub 2023 Nov 10. Aging (Albany NY). 2023. PMID: 37955651 Free PMC article.
-
Bagheri V, Esmaeili SA, Gholamin M, Abbaszadegan MR. Bagheri V, et al. Iran J Biotechnol. 2022 Apr 1;20(2):e3045. doi: 10.30498/ijb.2021.284841.3045. eCollection 2022 Apr. Iran J Biotechnol. 2022. PMID: 36337066 Free PMC article.
References
-
- Shapiro JR, Yung WKA, Shapiro WR. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res. 1981;41:2349–2359. - PubMed
-
- Yung WKA, Shapiro JR, Shapiro WR. Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res. 1982;42:992–998. - PubMed
-
- Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM, et al.Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature [Internet]. 2011;469:356–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21160474. - PubMed
-
- Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing. N. Engl J Med. [Internet]. 2012;366:883–92. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1113205. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources